Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Colorectal Neoplasms

  Free Subscription


05.10.2026

1 Ann Surg Oncol
6 Anticancer Res
2 BMC Cancer
1 BMC Gastroenterol
3 Br J Cancer
1 Clin Cancer Res
2 Dis Colon Rectum
1 Eur J Cancer
1 Gastroenterology
1 Gastrointest Endosc
1 Gut
1 Int J Cancer
1 J Nucl Med
2 J Surg Oncol
1 Oncol Rep
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Surg Oncol

  1. HASHIMOTO S, Tominaga T, Shiraishi T, Noda K, et al
    ASO Visual Abstract: Salvage R0 Resection on Post-Recurrence Survival After Pulmonary Metastasectomy for Colorectal Cancer: A Multicenter Retrospective Study.
    Ann Surg Oncol. 2026 Sep 28. doi: 10.1245/s10434-026-20636.
    PubMed        


    Anticancer Res

  2. SEKI Y, Shibutani M, Tanda H, Tsukida T, et al
    Vascular Proliferation Index Via a Single-Cell Analysis Is a Superior Prognostic Biomarker to Microvessel Density in Stage II/III Colorectal Cancer.
    Anticancer Res. 2026;46:5505-5515.
    PubMed         Abstract available

  3. HARAGUCHI N, Yokoyama Y, Kubota Y, Kouda S, et al
    Hyperthermia Enhances the Effects of ICI by Increasing PD-L1 Expression Through Induction of CD8(+) Cell Infiltration.
    Anticancer Res. 2026;46:5399-5410.
    PubMed         Abstract available

  4. ARIZONO M, Furukawa K, Tsunematsu M, Yamahata Y, et al
    Post-hepatectomy-related DIC Predicts Poor Survival After Resection for Colorectal Liver Metastases.
    Anticancer Res. 2026;46:5599-5608.
    PubMed         Abstract available

  5. KAWAZOE T, Ando K, Ryujin K, Nambara S, et al
    Real-world Outcomes of Trifluridine/Tipiracil With or Without Bevacizumab in Metastatic Colorectal Cancer: A Retrospective Cohort Study.
    Anticancer Res. 2026;46:5553-5564.
    PubMed         Abstract available

  6. CRISTAUDO AT, Morris DL
    Computational Modelling of CEA-CEAR Receptor Occupancy for Anti-CEA Therapy in Colorectal Liver Metastasis.
    Anticancer Res. 2026;46:5411-5419.
    PubMed         Abstract available

  7. YAMANE T, Masuda T, Nagayama Y, Adachi Y, et al
    Multidisciplinary Treatment With Repeated Thermal Ablation for Multisite Metastatic Colon Cancer in an Elderly Patient.
    Anticancer Res. 2026;46:5789-5797.
    PubMed         Abstract available


    BMC Cancer

  8. QIU J, Ye Y, Yu Y, Wang Z, et al
    Leveraging data-driven risk-adapted surveillance strategies after disease progression in locally advanced rectal cancer.
    BMC Cancer. 2026;26:1163.
    PubMed         Abstract available

  9. ZHUANG Z, Jiang L, Zhang F, Zhu H, et al
    CT-based Node-RADS classification in the assessment of rectal cancer: diagnostic performance and postoperative prognostic stratification.
    BMC Cancer. 2026;26:1154.
    PubMed         Abstract available


    BMC Gastroenterol

  10. ZHAO Y, Cao X, Niu L, Yang Z, et al
    Effectiveness of digital health interventions for the management of Low Anterior Resection Syndrome (LARS) after sphincter-preserving surgery for rectal cancer: a systematic review and meta-analysis.
    BMC Gastroenterol. 2026;26:590.
    PubMed         Abstract available


    Br J Cancer

  11. KAWAKAMI T, Masuishi T, Hamano T, Chida A, et al
    A prospective observational study of treatment sequencing with regorafenib and FTD/TPI in metastatic colorectal cancer: The OSERO study.
    Br J Cancer. 2026 Sep 29. doi: 10.1038/s41416-026-03620.
    PubMed         Abstract available

  12. SHI Y, Zhai ZW, Cao K, Ye CX, et al
    Neoadjuvant chemotherapy as a bridge to surgery versus direct surgery following SEMS placement in obstructive left-sided colon cancer: a multicenter prospective cohort study.
    Br J Cancer. 2026 Sep 29. doi: 10.1038/s41416-026-03623.
    PubMed         Abstract available

  13. HUISMANS MA, Gort EH, van der Heijden LT, Guven Mese SM, et al
    Correction: Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.
    Br J Cancer. 2026 Sep 25. doi: 10.1038/s41416-026-03616.
    PubMed        


    Clin Cancer Res

  14. PAPPAS L, Koenig JL, Yeap BY, Clark JW, et al
    A Phase II Study of Nivolumab and Ipilimumab with Radiation Therapy in Patients with Metastatic, Microsatellite Stable Colorectal Cancer.
    Clin Cancer Res. 2026 Oct 1. doi: 10.1158/1078-0432.CCR-26-1261.
    PubMed         Abstract available


    Dis Colon Rectum

  15. KAHANA N, Perets M, Horesh N, Boaz E, et al
    Trends and Survival Outcomes of Adjuvant Chemotherapy in Low-Risk Stage II Colon Cancer: A National Cancer Database Analysis.
    Dis Colon Rectum. 2026 Sep 30. doi: 10.1097/DCR.0000000000004486.
    PubMed         Abstract available

  16. PARSEGHIAN C, Rogers JE, Smith GL, Serpas Higbie V, et al
    Young-Onset Colorectal Cancer in Pregnancy and the Peri-Partum Period: A Framework for Developing A Coordinated, Personalized Care Plan.
    Dis Colon Rectum. 2026 Oct 1. doi: 10.1097/DCR.0000000000004485.
    PubMed        


    Eur J Cancer

  17. DENOST Q, Rouanet P, Teruel E, Borg C, et al
    Oncological impact of adjuvant chemotherapy after rectal cancer excision in the era of FOLFIRINOX-based TNT: A pooled post-hoc analysis of GRECCAR4-PRODIGE23.
    Eur J Cancer. 2026;247:117046.
    PubMed         Abstract available


    Gastroenterology

  18. REX DK, Anderson JC, Burke CA, Jacobson BC, et al
    Serrated Polyposis Syndrome: A Review and Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.
    Gastroenterology. 2026 Sep 30:S0016-5085(26)07240.
    PubMed         Abstract available


    Gastrointest Endosc

  19. REX DK, Anderson JC, Burke CA, Jacobson BC, et al
    Serrated Polyposis Syndrome: A Review and Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.
    Gastrointest Endosc. 2026 Sep 30:S0016-5107(26)07031.
    PubMed         Abstract available


    Gut

  20. MADDALENA G, Aziz K, Sun R, Newhook TE, et al
    Clinical impact of prospective circulating tumour DNA testing for minimal residual disease in colorectal cancer: the INTERCEPT programme experience.
    Gut. 2026 Oct 1:gutjnl-2026-339167. doi: 10.1136/gutjnl-2026-339167.
    PubMed         Abstract available


    Int J Cancer

  21. OPPERMAN RCM, Bosch S, Henneman AA, Pham TV, et al
    Human Protein Biomarkers Outperform Bacterial Proteins in Colorectal Cancer Detection.
    Int J Cancer. 2026 Oct 1. doi: 10.1002/ijc.70760.
    PubMed         Abstract available


    J Nucl Med

  22. GRONNINGSAETER SR, Blakkisrud J, Kvassheim M, Westrom S, et al
    Normal Tissue Dosimetry of Intraperitoneal (224)Ra Microparticle Therapy: Data from First-in-Human Studies in Patients with Peritoneal Metastases.
    J Nucl Med. 2026;67:1644-1651.
    PubMed         Abstract available


    J Surg Oncol

  23. WAQAR U, Rupji M, Salar M, Salar H, et al
    Impact of Adjuvant Chemotherapy on Overall Survival in Early-Onset Stage II-III Mucinous Adenocarcinoma of The Colon: A Propensity-Based Analysis.
    J Surg Oncol. 2026;134:720-729.
    PubMed         Abstract available

  24. WONG TN, Kong CY, Ishak P, Galbraith N, et al
    Peri-Operative Systemic Inflammatory Responses Predict Post-Operative Complications in Patients Undergoing Pelvic Exenterative Surgery for Primary Locally Advanced Sigmoid and Rectal Cancer.
    J Surg Oncol. 2026;134:639-653.
    PubMed         Abstract available


    Oncol Rep

  25. MA F, Bi L, Yang G, Zhang M, et al
    [Expression of Concern] ZNF703 promotes tumor cell proliferation and invasion and predicts poor prognosis in patients with colorectal cancer.
    Oncol Rep. 2026;56:199.
    PubMed         Abstract available


    PLoS One

  26. JEON Y, Sym SJ, Lee WS, Baek JH, et al
    Long-term oncologic outcomes associated with clinically significant anastomotic leakage after curative colorectal cancer surgery: Stage- and location-stratified analyses.
    PLoS One. 2026;21:e0359416.
    PubMed         Abstract available

  27. SERTESEN CAMOZ E, Kaya OB, Ercelebi H, Karacin C, et al
    Distinct NGS mutational landscape and prognostic implications in early-onset colorectal cancer: A dual-cohort analysis of TCGA PanCancer Atlas and MSK-IMPACT 50K.
    PLoS One. 2026;21:e0359094.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum